Depression, anxiety, and neuropsychological performance in coronary artery bypass graft patients: a follow-up study

Nathalie Stroobant1, Guy Vingerhoets

  • 1University Hospital, Ghent, Laboratory for Neuropsychology, 4K3, De Pintelaan 185, B-9000, Ghent, Belgium. Nathalie.Stroobant@UGent.be

Psychosomatics
|July 16, 2008
PubMed

Insights

Coronary-artery bypass surgery (CABG) can impact mood. Some patients experience lasting depression, especially those with pre-operative symptoms, while anxiety typically decreases post-surgery.

Area of Science:

  • Cardiology
  • Psychiatry
  • Neuropsychology

Background:

  • Coronary-artery bypass surgery (CABG) is a major life event with significant psycho-emotional effects.
  • Patient and family well-being are impacted by the surgical experience.

Purpose of the Study:

  • To investigate the incidence and progression of depression and anxiety in patients.
  • To examine the long-term relationship between mood disorders and neuropsychological deficits after CABG.

Main Methods:

  • Prospective study of 53 patients undergoing CABG.
  • Mood and neuropsychological assessments were conducted pre-surgery and at 6 days, 6 months, and 3-5 years post-surgery.

Main Results:

  • One-third of patients exhibited mild-to-moderate depressive symptoms pre-surgery.
  • Post-surgery, one-fourth of patients still had elevated depression scores, but anxiety decreased significantly.
  • Pre-operative depression severity correlated with sustained post-operative depressive symptoms.
  • Visuomotor performance was most affected by mood disturbances.

Conclusions:

  • Patients with moderate pre-operative depression are at risk for persistent depression up to 5 years after CABG.
  • Early identification and management of pre-operative depression are crucial for long-term patient outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...